Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer

Fig. 3

5α-reductase inhibition prevents wound closure and migration of bladder cancer cells induced by testosterone treatment A–D Wound closure analysis: representative images of T24 (A) and J82 (C) cells. The graphs on the left indicate the percentage of wound closure with or without testosterone (T) and dutasteride (Duta.) treatments. N = 3. E Transwell migration analysis: Images showing the effect of dutasteride treatment on migration and graph showing the relative migrated area. N = 3. All values are shown as mean ± SD of at least three independent experiments, two-way ANOVA in wound closure assay and one-way ANOVA in transwell migration assay followed by Tukey’s post-hoc test. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page